In a retrospective cohort study, researchers investigated the treatment patterns for adults in the United States with alopecia areata from 2015 to 2020.
In a recent study presented at the American Academy of Dermatology’s annual meeting, researchers examined the efficacy of various doses of an oral JAK1/JAK2 inhibitor for treating patients with...
In a post-hoc analysis of the ALLEGRO phase 2b/3 trial, researchers evaluated whether scalp, eyebrow, and eyelash hair regrowth would continue over 48 weeks in patients with alopecia areata treated with...
Researchers evaluated the efficacy of Janus kinase inhibitors in adult patients with alopecia areata. Their research was presented at the American Academy of Dermatology’s 2023 annual meeting in New...
In a recent study presented at the American Academy of Dermatology’s 2023 annual meeting, researchers examined the relationship between scalp hair loss severity and baseline distribution of eyebrow and...
Alopecia can have a significant negative impact on a patient’s quality of life, so it is important to understand its clinical features. This article summarizes a presentation on alopecia by Britt Craiglow,...
The US Food and Drug Administration has approved the first systemic treatment for alopecia areata following the publication of results from 2 randomized, placebo-controlled trials.
